Detalhe da pesquisa
1.
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
Breast Cancer Res
; 21(1): 58, 2019 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31060593
2.
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.
Breast Cancer Res
; 19(1): 113, 2017 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029636
3.
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.
Br J Cancer
; 114(1): 88-95, 2016 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26657655
4.
Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control.
BMC Genomics
; 14: 643, 2013 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24059244
5.
Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles.
Mod Pathol
; 26(7): 955-66, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23392436
6.
The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre.
Cancers (Basel)
; 14(2)2022 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053432
7.
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.
Br J Cancer
; 114(12): e23, 2016 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27228288
8.
Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma.
Cancers (Basel)
; 13(12)2021 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34207042
9.
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenon.
Breast
; 50: 39-48, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981910
10.
Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer.
Cancer Epidemiol Biomarkers Prev
; 28(7): 1162-1168, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263054
11.
Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survival.
Sci Rep
; 7: 40177, 2017 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28059167
12.
Family history of breast cancer and its association with disease severity and mortality.
Cancer Med
; 5(5): 942-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799372